Weight boss? Competition for Novo Nordisk - The Intelligence from The Economist Recap

Podcast: The Intelligence from The Economist

Published: 2025-12-18

Duration: 21 minutes

Guests: Shalice Chitnis

Summary

Novo Nordisk's dominance in the weight loss drug market is challenged by Eli Lilly's new product Zebbound, leading to significant shifts in market dynamics.

What Happened

Novo Nordisk, a Danish pharmaceutical company, dominated the weight loss drug market with its product Wegovy since 2021. However, Eli Lilly's introduction of a rival drug, Zebbound, in 2023 has shifted the competitive landscape. Zebbound quickly achieved significant sales and is projected to surpass Wegovy, leading to a substantial drop in Novo's market value.

Novo Nordisk's initial success was hampered by missteps, including underestimating the market size and facing challenges from compound pharmacies producing cut-price versions of Wegovy. Additionally, the company struggled to adapt to a consumer-driven market where demand is often out-of-pocket, unlike traditional pharma sales through insurers and doctors.

In response to these challenges, Novo Nordisk has made significant organizational changes, including appointing a new CEO, Maziar Mike Dustar, and restructuring its board. The company has also announced layoffs to 'right-size' and refocus on its core areas of obesity and diabetes treatment.

Novo Nordisk's new strategy involves shifting its mindset from a pharmaceutical company to one that thinks more like a consumer business. This involves adapting pricing strategies similar to consumer goods, which is a new approach for pharmaceutical companies.

Despite these efforts, it remains uncertain whether Novo Nordisk can regain its market position, as Eli Lilly's advantages in product efficacy and commercial channels are significant. The evolving weight loss market now emphasizes not just total weight loss but also reducing muscle mass loss and side effects.

The episode also explores the possibility that the first word uttered by humans could have been a slang term. Jonathan Green, an expert on English slang, suggests that early human language might have included words related to body parts or taboo subjects.

Key Insights